Zdrowie i gospodarka · 03/08/2015

FDA Hosts Sixth Annual Scientific Workshop on Alzheimer's and Parkinson's Disease

The Food and Drug Administration (FDA) is hosting a public workshop to discuss ongoing efforts to develop tools and methods for drug development of Alzheimer's and Parkinson's diseases, co-sponsored by the Coalition Against Major Diseases (CAMD) and the Critical Path Institute (C-Path).